25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GSTC (AngioSoma Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze AngioSoma Inc together

I guess you are interested in AngioSoma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – AngioSoma Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – AngioSoma Inc’s Price Targets

I'm going to help you getting a better view of AngioSoma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AngioSoma Inc

I send you an email if I find something interesting about AngioSoma Inc.

1. Quick Overview

1.1. Quick analysis of AngioSoma Inc (30 sec.)










1.2. What can you expect buying and holding a share of AngioSoma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-739.3%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of AngioSoma Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.00
Total Value Per Share
$0.00 - $0.00

2.2. Growth of AngioSoma Inc (5 min.)




Is AngioSoma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.4m-$1.1m-$229.3k-16.1%

How much money is AngioSoma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$1.4m190.000.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of AngioSoma Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#769 / 872

Most Revenue
#824 / 872

Most Profit
#273 / 872

Most Efficient
#383 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of AngioSoma Inc?

Welcome investor! AngioSoma Inc's management wants to use your money to grow the business. In return you get a share of AngioSoma Inc.

First you should know what it really means to hold a share of AngioSoma Inc. And how you can make/lose money.

Speculation

The Price per Share of AngioSoma Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of AngioSoma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in AngioSoma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of AngioSoma Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-1,198.8%0.00-1,198.8%0.00-1,198.8%0.00-3,431.7%0.00-2,512.9%-0.05-45,046.4%
Usd Book Value Change Per Share0.00-184.8%0.00-184.8%0.00-377.7%0.00-205.4%0.00-89.1%0.00-134.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.00257.8%0.004,303.6%
Usd Total Gains Per Share0.00-184.8%0.00-184.8%0.00-377.7%0.00-205.4%0.00168.7%0.004,169.2%
Usd Price Per Share0.00-0.00-0.00-0.01-0.01-0.89-
Price to Earnings Ratio-1.50--1.50--3.09--2.78--5.43--61.23-
Price-to-Total Gains Ratio-9.74--9.74--9.80--190.38--49.02-40.35-
Price to Book Ratio-1.57--1.57--3.84--18.68--15.90-3,996.25-
Price-to-Total Gains Ratio-9.74--9.74--9.80--190.38--49.02-40.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-1,848.231,686.85
Gains per Year (10000000 shares)-7,392.936,747.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-7393-740310313-35666737
20-14786-1479620627-713213484
30-22179-2218930940-1069820231
40-29572-2958241253-1426426978
50-36965-3697551567-1783033725
60-44358-4436861880-2139640472
70-51751-5176172193-2496247219
80-59143-5915482507-2852753966
90-66536-6654792820-3209360713
100-73929-73940103133-3565967460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.013.00.07.1%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.06.00.040.0%6.08.00.042.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%5.00.05.050.0%5.00.09.035.7%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%6.04.00.060.0%8.06.00.057.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AngioSoma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%0.000+104%0.000+11%0.000-52%0.000-27%
Book Value Per Share---0.001-0.0010%-0.001-16%-0.001-22%-0.001-34%-0.001-50%
Current Ratio----0%0.008-100%0.005-100%0.061-100%0.055-100%
Debt To Asset Ratio--144.615144.6150%121.480+19%129.626+12%80.606+79%48.942+195%
Debt To Equity Ratio----0%-0%-0%-0%2.450-100%
Dividend Per Share----0%-0%-0%0.000-100%0.004-100%
Enterprise Value--800137.029800137.0290%3393997.059-76%13401723.187-94%10914483.153-93%1100334600.996-100%
Eps---0.001-0.0010%-0.0010%-0.003+186%-0.003+110%-0.045+3658%
Ev To Ebitda Ratio---0.632-0.6320%-2.685+325%-2.426+284%-10.803+1608%-2165.151+342223%
Free Cash Flow Per Share--0.0000.0000%0.000+59%0.000+108%0.000+74%0.000+40%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-1672%0.000+327%0.000+188%0.000+46%
Gross Profit Margin--1.4031.4030%1.000+40%1.134+24%1.081+30%1.045+34%
Intrinsic Value_10Y_max---0.001----------
Intrinsic Value_10Y_min---0.003----------
Intrinsic Value_1Y_max--0.000----------
Intrinsic Value_1Y_min--0.000----------
Intrinsic Value_3Y_max--0.000----------
Intrinsic Value_3Y_min---0.001----------
Intrinsic Value_5Y_max---0.001----------
Intrinsic Value_5Y_min---0.002----------
Market Cap124111.002-1700%2233998.0292233998.0290%4592107.059-51%14520987.187-85%11865011.753-81%1101137628.396-100%
Net Profit Margin----0%-0%-0%-1725.4390%-958.3820%
Operating Margin----0%-0%-0%-935.8540%-550.1860%
Operating Ratio----0%-0%-0%937.801-100%510.527-100%
Pb Ratio-0.087+94%-1.569-1.5690%-3.844+145%-18.676+1090%-15.903+914%3996.245-100%
Pe Ratio-0.083+94%-1.502-1.5020%-3.086+106%-2.779+85%-5.427+261%-61.229+3978%
Price Per Share0.000-1700%0.0020.0020%0.004-51%0.012-85%0.010-81%0.887-100%
Price To Free Cash Flow Ratio-0.603+94%-10.857-10.8570%-14.043+29%-24.601+127%-27.379+152%-7689.576+70724%
Price To Total Gains Ratio-0.541+94%-9.739-9.7390%-9.797+1%-190.383+1855%-49.017+403%40.351-124%
Quick Ratio----0%0.005-100%0.004-100%0.049-100%3.717-100%
Return On Assets---150.056-150.0560%-150.076+0%-648.254+332%-391.108+161%-222.718+48%
Return On Equity----0%-0%-0%-0%-8.5910%
Total Gains Per Share--0.0000.0000%0.000+104%0.000+11%0.000-210%0.004-104%
Usd Book Value---1423946.000-1423946.0000%-1194560.000-16%-1114775.667-22%-937796.800-34%-711857.200-50%
Usd Book Value Change Per Share--0.0000.0000%0.000+104%0.000+11%0.000-52%0.000-27%
Usd Book Value Per Share---0.001-0.0010%-0.001-16%-0.001-22%-0.001-34%-0.001-50%
Usd Dividend Per Share----0%-0%-0%0.000-100%0.004-100%
Usd Enterprise Value--800137.029800137.0290%3393997.059-76%13401723.187-94%10914483.153-93%1100334600.996-100%
Usd Eps---0.001-0.0010%-0.0010%-0.003+186%-0.003+110%-0.045+3658%
Usd Free Cash Flow---205760.000-205760.0000%-326995.000+59%-427995.667+108%-357128.400+74%-288342.900+40%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+59%0.000+108%0.000+74%0.000+40%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-1672%0.000+327%0.000+188%0.000+46%
Usd Market Cap124111.002-1700%2233998.0292233998.0290%4592107.059-51%14520987.187-85%11865011.753-81%1101137628.396-100%
Usd Price Per Share0.000-1700%0.0020.0020%0.004-51%0.012-85%0.010-81%0.887-100%
Usd Profit---1487810.000-1487810.0000%-1488000.000+0%-4259270.000+186%-2798962.000+88%-2211581.000+49%
Usd Revenue----0%-0%-0%100.400-100%13310679.700-100%
Usd Total Gains Per Share--0.0000.0000%0.000+104%0.000+11%0.000-210%0.004-104%
 EOD+2 -6MRQTTM+0 -0YOY+13 -163Y+17 -145Y+14 -2110Y+15 -21

3.3 Fundamental Score

Let's check the fundamental score of AngioSoma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.083
Price to Book Ratio (EOD)Between0-1-0.087
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than1144.615
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-150.056
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of AngioSoma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.560
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About AngioSoma Inc

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, offers a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.

Fundamental data was last updated by Penke on 2025-06-29 17:22:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ AngioSoma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AngioSoma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-172,543.9%+172,543.9%
5Y-172,543.9%10Y-95,838.2%-76,705.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM--140.3%+140.3%
YOY--196.4%+196.4%
3Y--248.5%+248.5%
5Y-172,543.9%-343.4%-172,200.5%
10Y-95,838.2%-496.2%-95,342.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ AngioSoma Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • -15,005.6% Return on Assets means thatΒ AngioSoma Inc generatedΒ $-150.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AngioSoma Inc:

  • The MRQ is -15,005.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15,005.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15,005.6%TTM-15,005.6%0.0%
TTM-15,005.6%YOY-15,007.6%+1.9%
TTM-15,005.6%5Y-39,110.8%+24,105.1%
5Y-39,110.8%10Y-22,271.8%-16,839.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15,005.6%-11.6%-14,994.0%
TTM-15,005.6%-11.6%-14,994.0%
YOY-15,007.6%-11.4%-14,996.2%
3Y-64,825.4%-11.8%-64,813.6%
5Y-39,110.8%-12.0%-39,098.8%
10Y-22,271.8%-13.7%-22,258.1%
4.3.1.3. Return on Equity

Shows how efficient AngioSoma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means AngioSoma Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AngioSoma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-859.1%+859.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM--15.0%+15.0%
YOY--14.5%+14.5%
3Y--16.9%+16.9%
5Y--17.5%+17.5%
10Y-859.1%-19.9%-839.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AngioSoma Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient AngioSoma Inc is operatingΒ .

  • Measures how much profit AngioSoma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AngioSoma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-93,585.4%+93,585.4%
5Y-93,585.4%10Y-55,018.6%-38,566.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--249.0%+249.0%
YOY--208.5%+208.5%
3Y--223.8%+223.8%
5Y-93,585.4%-346.1%-93,239.3%
10Y-55,018.6%-475.5%-54,543.1%
4.3.2.2. Operating Ratio

Measures how efficient AngioSoma Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AngioSoma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y937.801-937.801
5Y937.80110Y510.527+427.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.684-2.684
YOY-3.096-3.096
3Y-3.652-3.652
5Y937.8014.745+933.056
10Y510.5276.614+503.913
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AngioSoma Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if AngioSoma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.00Β means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AngioSoma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.008-0.008
TTM-5Y0.061-0.061
5Y0.06110Y0.055+0.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.661-3.661
TTM-3.846-3.846
YOY0.0084.140-4.132
3Y0.0054.688-4.683
5Y0.0615.746-5.685
10Y0.0556.147-6.092
4.4.3.2. Quick Ratio

Measures if AngioSoma Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AngioSoma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.005-0.005
TTM-5Y0.049-0.049
5Y0.04910Y3.717-3.668
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.826-2.826
TTM-3.182-3.182
YOY0.0053.786-3.781
3Y0.0044.311-4.307
5Y0.0495.703-5.654
10Y3.7176.454-2.737
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AngioSoma Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AngioSoma IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ AngioSoma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 144.62Β means that AngioSoma Inc assets areΒ financed with 14,461.5% credit (debt) and the remaining percentage (100% - 14,461.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of AngioSoma Inc:

  • The MRQ is 144.615. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 144.615. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ144.615TTM144.6150.000
TTM144.615YOY121.480+23.135
TTM144.6155Y80.606+64.009
5Y80.60610Y48.942+31.664
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ144.6150.329+144.286
TTM144.6150.349+144.266
YOY121.4800.331+121.149
3Y129.6260.340+129.286
5Y80.6060.349+80.257
10Y48.9420.379+48.563
4.5.4.2. Debt to Equity Ratio

Measures ifΒ AngioSoma Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AngioSoma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y2.450-2.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY-0.414-0.414
3Y-0.450-0.450
5Y-0.464-0.464
10Y2.4500.515+1.935
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings AngioSoma Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ AngioSoma Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -1.50 means the investor is paying $-1.50Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AngioSoma Inc:

  • The EOD is -0.083. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.502. Based on the earnings, the company is expensive. -2
  • The TTM is -1.502. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.083MRQ-1.502+1.418
MRQ-1.502TTM-1.5020.000
TTM-1.502YOY-3.086+1.585
TTM-1.5025Y-5.427+3.925
5Y-5.42710Y-61.229+55.802
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.083-2.304+2.221
MRQ-1.502-2.080+0.578
TTM-1.502-2.564+1.062
YOY-3.086-3.764+0.678
3Y-2.779-3.773+0.994
5Y-5.427-6.193+0.766
10Y-61.229-6.833-54.396
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AngioSoma Inc:

  • The EOD is -0.603. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.857. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.857. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.603MRQ-10.857+10.254
MRQ-10.857TTM-10.8570.000
TTM-10.857YOY-14.043+3.186
TTM-10.8575Y-27.379+16.522
5Y-27.37910Y-7,689.576+7,662.197
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.603-3.132+2.529
MRQ-10.857-2.705-8.152
TTM-10.857-3.666-7.191
YOY-14.043-4.405-9.638
3Y-24.601-5.059-19.542
5Y-27.379-8.477-18.902
10Y-7,689.576-9.304-7,680.272
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ AngioSoma Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -1.57 means the investor is paying $-1.57Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AngioSoma Inc:

  • The EOD is -0.087. Based on the equity, the company is expensive. -2
  • The MRQ is -1.569. Based on the equity, the company is expensive. -2
  • The TTM is -1.569. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.087MRQ-1.569+1.482
MRQ-1.569TTM-1.5690.000
TTM-1.569YOY-3.844+2.275
TTM-1.5695Y-15.903+14.334
5Y-15.90310Y3,996.245-4,012.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0871.953-2.040
MRQ-1.5691.843-3.412
TTM-1.5692.112-3.681
YOY-3.8442.441-6.285
3Y-18.6762.494-21.170
5Y-15.9033.661-19.564
10Y3,996.2454.311+3,991.934
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets-
Total Liabilities1,434
Total Stockholder Equity-1,434
 As reported
Total Liabilities 1,434
Total Stockholder Equity+ -1,434
Total Assets = -

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,434
Long-term Liabilities-
Total Stockholder Equity-1,434
Total Current Liabilities
Short-term Debt 360
Accounts payable 328
Other Current Liabilities 860
Total Current Liabilities  (as reported)1,434
Total Current Liabilities  (calculated)1,548
+/- 114
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock996
Retained Earnings -20,454
Accumulated Other Comprehensive Income -1,434
Other Stockholders Equity 19,457
Total Stockholder Equity (as reported)-1,434
Total Stockholder Equity (calculated)-1,435
+/- 1
Other
Common Stock Shares Outstanding 827,325
Current Deferred Revenue-114
Net Debt 360
Short Long Term Debt Total 360



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-12-312023-09-302022-12-312022-09-302021-12-312021-09-302020-12-312020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-30
> Total Assets 
9
22
282
463
478
322
17
25
125
142
90
90
6
6
10
10
0
0
0010106690901421252517322478463282229
   > Total Current Assets 
9
22
1
138
29
11
7
15
112
141
89
89
6
6
10
10
0
0
00101066898914111215711291381229
       Cash And Cash Equivalents 
9
22
1
128
1
6
6
14
92
100
81
81
6
6
6
6
0
0
006666818110092146611281229
       Net Receivables 
0
0
0
10
16
5
26,883
0
0
0
0
0
0
0
0
0
0
0
0000000000026,88351610000
       Other Current Assets 
0
0
0
0
12
1
1
1
16
1
5
5
0
0
4
0
0
0
00040055116111120000
   > Long-term Assets 
0
0
281
324
448
311
11
10
13
1
1
1
0
0
0
0
0
0
00000011113101131144832428100
       Property Plant Equipment 
0
0
281
324
396
255
192,004
325,095
1
1
1
1
3
0
0
0
0
0
0000031111325,095192,00425539632428100
       Long Term Investments 
0
0
0
0
0
0
0
10
12
0
0
0
0
0
0
0
0
0
00000000012100000000
       Other Assets 
0
0
0
0
19,875
15,595
2,821
857
0
0
0
0
0
0
0
0
0
0
00000000008572,82115,59519,8750000
> Total Liabilities 
2
32
388
217
582
310
860
649
995
828
749
749
732
732
1,204
1,204
1,434
1,434
1,4341,4341,2041,204732732749749828995649860310582217388322
   > Total Current Liabilities 
2
32
358
121
561
247
732
505
995
828
749
749
732
732
1,204
1,204
1,434
1,434
1,4341,4341,2041,204732732749749828995505732247561121358322
       Short-term Debt 
0
28
329
0
248
66
428
89
285
114
155
155
106
106
20
20
366
360
360366202010610615515511428589428662480329280
       Short Long Term Debt 
0
0
0
0
360,303
516,476
404,493
342,952
345
173
215
0
166
0
20
0
360
0
036002001660215173345342,952404,493516,476360,3030000
       Accounts payable 
2
4
29
114
246
131
165
137
137
135
133
133
223
223
381
381
328
328
3283283813812232231331331351371371651312461142942
       Other Current Liabilities 
0
28
329
8
67
50
139
348
573
579
461
461
403
403
804
804
740
860
86074080480440340346146157957334813950678329280
   > Long-term Liabilities 
2
4
31
96
21
63
128
144
422
422
289
0
329
0
1
1
0
0
0011032902894224221441286321963142
       Other Liabilities 
0
0
0
0
10,177
9,236
6,412
75
0
0
0
0
0
0
0
0
0
0
0000000000756,4129,23610,1770000
       Deferred Long Term Liability 
0
0
0
0
2,586
985
676
0
0
0
0
0
0
0
0
0
0
0
000000000006769852,5860000
> Total Stockholder Equity
7
-10
-106
245
-104
13
-843
-624
-871
-685
-659
-659
-726
-726
-1,195
-1,195
-1,434
-1,434
-1,434-1,434-1,195-1,195-726-726-659-659-685-871-624-84313-104245-106-107
   Common Stock
1
1
1
1
3
9
34
46
69
170
436
436
561
561
722
722
996
996
996996722722561561436436170694634931111
   Retained Earnings -20,454-20,454-18,505-18,505-17,017-17,017-7,215-7,215-6,674-5,999-5,182-3,502-4,442-3,357-2,112-1,145-56-2
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
8
46
1,059
2,356
3,232
4,424
2,625
1,521
2,065
1,225
6,118
6,118
15,228
15,228
16,581
16,581
18,023
19,457
19,45718,02316,58116,58115,22815,2286,1186,1181,2252,0651,5212,6254,4243,2322,3561,059468



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-1,265
Operating Income-1,265-1,265
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,265
Selling And Marketing Expenses-
Operating Expense1,2651,265
 
Net Interest Income (+$)
Interest Income-
Interest Expense-70
Other Finance Cost-70
Net Interest Income-
 
Pretax Income (+$)
Operating Income-1,265
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,488-1,042
EBIT - interestExpense = -1,337
-1,490
-1,417
Interest Expense70
Earnings Before Interest and Taxes (EBIT)-1,267-1,417
Earnings Before Interest and Taxes (EBITDA)-1,265
 
After tax Income (+$)
Income Before Tax-1,488
Tax Provision--
Net Income From Continuing Ops--1,488
Net Income-1,488
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,265
Total Other Income/Expenses Net-2230
 

Technical Analysis of AngioSoma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of AngioSoma Inc. The general trend of AngioSoma Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine AngioSoma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. AngioSoma Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AngioSoma Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Know someone who trades $GSTC? Share this with them.πŸ‘‡

AngioSoma Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AngioSoma Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AngioSoma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AngioSoma Inc. The current macd is 0.00000.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the AngioSoma Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for AngioSoma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the AngioSoma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
AngioSoma Inc Daily Moving Average Convergence/Divergence (MACD) ChartAngioSoma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AngioSoma Inc. The current adx is 57.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell AngioSoma Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
AngioSoma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AngioSoma Inc. The current sar is 0.00017896.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
AngioSoma Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AngioSoma Inc. The current rsi is 30.56. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
AngioSoma Inc Daily Relative Strength Index (RSI) ChartAngioSoma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AngioSoma Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the AngioSoma Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
AngioSoma Inc Daily Stochastic Oscillator ChartAngioSoma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AngioSoma Inc. The current cci is -66.66666667.

AngioSoma Inc Daily Commodity Channel Index (CCI) ChartAngioSoma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AngioSoma Inc. The current cmo is -58.82382987.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
AngioSoma Inc Daily Chande Momentum Oscillator (CMO) ChartAngioSoma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AngioSoma Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
AngioSoma Inc Daily Williams %R ChartAngioSoma Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of AngioSoma Inc.

AngioSoma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AngioSoma Inc. The current atr is 0.00000.

AngioSoma Inc Daily Average True Range (ATR) ChartAngioSoma Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AngioSoma Inc. The current obv is -258,280,847.

AngioSoma Inc Daily On-Balance Volume (OBV) ChartAngioSoma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AngioSoma Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
AngioSoma Inc Daily Money Flow Index (MFI) ChartAngioSoma Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AngioSoma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

AngioSoma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AngioSoma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.560
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of AngioSoma Inc with someone you think should read this too:
  • Are you bullish or bearish on AngioSoma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about AngioSoma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AngioSoma Inc

I send you an email if I find something interesting about AngioSoma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about AngioSoma Inc.

Receive notifications about AngioSoma Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.